NFL Biosciences
Biopharmaceutical company developing botanical drug candidates for addiction treatment.
ALNFL | PA
Overview
Corporate Details
- ISIN(s):
- FR0014003XO1 (+1 more)
- LEI:
- 9695006VJWNTN4UNHA27
- Country:
- France
- Address:
- 199 RUE HELENE BOUCHER, 34170 CASTELNAU-LE-LEZ
- Website:
- https://www.nflbiosciences.com/
Description
NFL Biosciences is a biopharmaceutical company that develops botanical drug candidates for the treatment of addictions. The company's lead product, NFL-101, is a nicotine-free drug candidate for smoking cessation derived from a protein extract of tobacco leaves. Its development pipeline also includes NFL-301, a candidate aimed at reducing excessive alcohol consumption. NFL Biosciences focuses on advancing its products through clinical trials with the goal of licensing them to pharmaceutical companies for commercialization.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-08 17:45 |
Informations privilégiées / Autres communiqués
|
French | 201.4 KB | ||
| 2025-12-08 17:45 |
Inside Information / Other news releases
|
English | 202.8 KB | ||
| 2025-11-12 08:00 |
Inside Information / Other news releases
|
English | 174.6 KB | ||
| 2025-11-12 08:00 |
Informations privilégiées / Autres communiqués
|
French | 196.7 KB | ||
| 2025-10-20 18:00 |
Inside Information / Other news releases
|
English | 246.7 KB | ||
| 2025-10-20 18:00 |
Informations privilégiées / Autres communiqués
|
French | 239.3 KB | ||
| 2025-10-17 17:45 |
Rapports financiers et d'audit semestriels/examens réduits / Modalités de mise …
|
French | 215.8 KB | ||
| 2025-10-16 17:45 |
Inside Information / News release on accounts, results
|
English | 340.8 KB | ||
| 2025-10-16 17:45 |
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 359.6 KB | ||
| 2025-09-01 18:00 |
Informations privilégiées / Autres communiqués
|
French | 298.2 KB | ||
| 2025-09-01 18:00 |
Inside Information / Other news releases
|
English | 318.5 KB | ||
| 2025-07-28 08:30 |
Informations privilégiées / Autres communiqués
|
French | 224.2 KB | ||
| 2025-07-28 08:30 |
Inside Information / Other news releases
|
English | 246.1 KB | ||
| 2025-07-22 08:30 |
Inside Information / Other news releases
|
English | 246.7 KB | ||
| 2025-07-22 08:30 |
Informations privilégiées / Autres communiqués
|
French | 245.5 KB |
Automate Your Workflow. Get a real-time feed of all NFL Biosciences filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NFL Biosciences
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NFL Biosciences via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
